News

Hosted on MSN23d
ADA Advises Against Compounded GLP-1s; Growth Hormone Therapy Guide; T1D Outcomes Up
The American Diabetes Association (ADA) urged healthcare providers against prescribing non-FDA approved compounded GLP-1 and dual GIP/GIP-1 receptor agonists for type 2 diabetes or obesity and ...
pharmaphorum5d
IBM Watson and ADA team to help drive diabetes management innovation
IBM Watson and the American Diabetes Association (ADA) will collaborate to create better disease management tools for those affected by diabetes. The project, unveiled at the ADA’s 76 th ...